Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RAPGEF6 SERGEF EIF2B4 DNMBP PLEKHG7 ARHGEF5 DENND3 RAB3GAP1 DOCK7 RASGEF1C RAPGEF2	1.46e-05	231	191	11	GO:0005085
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	RELN RIPOR2 RAPGEF6 ABL2 BCL6 DNMBP COL1A2 FOXM1 PLEKHG7 ARHGEF5 CBL RUFY1 SYDE1 DENND3 ARHGAP5 CELSR1 DOCK7 RASGEF1C RAPGEF2	6.64e-07	538	191	19	GO:0007264
MousePheno	abnormal neural tube closure	LUZP1 PRRC2C KDM6A HUS1 LASP1 MSGN1 GRIP1 RBM22 CELSR1 EGR1 TRIM28 TET1 PAK2 PKN2 RAPGEF2 TP53BP2	3.28e-06	378	151	16	MP:0003720
MousePheno	anencephaly	LUZP1 NDST1 TET1 TRAPPC10 RAPGEF2	4.96e-06	24	151	5	MP:0001890
MousePheno	abnormal nervous system development	RELN LUZP1 CFAP54 PRRC2C DNAH5 KDM6A NDST1 FAT4 FN1 HUS1 ARHGEF5 APOB LASP1 MSI1 GTF2IRD1 AK8 MSGN1 GRIP1 RBM22 CELSR1 EGR1 TRIM28 TET1 TRAPPC10 PAK2 ZFYVE26 PKN2 RAPGEF2 ATP2B2 TP53BP2	2.65e-05	1257	151	30	MP:0003861
MousePheno	abnormal neural tube morphology	LUZP1 PRRC2C KDM6A FAT4 FN1 HUS1 LASP1 MSGN1 GRIP1 RBM22 CELSR1 EGR1 TRIM28 TET1 PAK2 PKN2 RAPGEF2 TP53BP2	6.89e-05	591	151	18	MP:0002151
Domain	-	ILDR2 IL13RA2 MYLK PSG9 INSRR IGSF10 NFATC1 NECTIN2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 USH2A CNTN2 COL6A3 IL31RA FN1 LRRN1 ICAM1	4.21e-05	663	188	19	2.60.40.10
Domain	Ig-like_fold	ILDR2 IL13RA2 MYLK PSG9 INSRR IGSF10 NFATC1 NECTIN2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 USH2A CNTN2 COL6A3 IL31RA FN1 LRRN1 ICAM1	9.68e-05	706	188	19	IPR013783
Domain	FN3	IL13RA2 MYLK INSRR USH2A CNTN2 COL6A3 IL31RA FN1 LRRN1	1.91e-04	199	188	9	PS50853
Domain	EGF_1	RELN PTGS1 FAT2 USH2A NPNT FAT4 FN1 ADAM32 CELSR1 MEGF10	2.69e-04	255	188	10	PS00022
Domain	FN3_dom	IL13RA2 MYLK INSRR USH2A CNTN2 COL6A3 IL31RA FN1 LRRN1	2.75e-04	209	188	9	IPR003961
Domain	ALMS_motif	ALMS1 C10orf90	3.00e-04	3	188	2	IPR029299
Domain	ALMS_motif	ALMS1 C10orf90	3.00e-04	3	188	2	PF15309
Domain	ATPase_dyneun-rel_AAA	VWA8 DNAH5 DNAH8	3.37e-04	14	188	3	IPR011704
Domain	AAA_5	VWA8 DNAH5 DNAH8	3.37e-04	14	188	3	PF07728
Domain	SH3	ABL2 MYO7A DLG2 DNMBP CASS4 ARHGEF5 LASP1 MYO15A TP53BP2	3.50e-04	216	188	9	SM00326
Domain	SH3	ABL2 MYO7A DLG2 DNMBP CASS4 ARHGEF5 LASP1 MYO15A TP53BP2	3.50e-04	216	188	9	PS50002
Domain	SH3_domain	ABL2 MYO7A DLG2 DNMBP CASS4 ARHGEF5 LASP1 MYO15A TP53BP2	4.00e-04	220	188	9	IPR001452
Domain	LAM_G_DOMAIN	FAT2 USH2A FAT4 CELSR1	5.62e-04	38	188	4	PS50025
Domain	FN3	MYLK INSRR USH2A CNTN2 COL6A3 IL31RA FN1 LRRN1	5.83e-04	185	188	8	SM00060
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RAPGEF6 LUZP1 ALMS1 PRRC2C KMT2A TAF4 KDM6A CDV3 CBL RUFY1 USP10 YEATS4 TRIM28 TET1 DOCK7 PAK2 PKN2 QSER1 SKA3 SPEN CUX1 TP53BP2	6.79e-13	549	194	22	38280479
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GGA2 EIF2B4 NECTIN2 UGDH CYB5R3 AHSG ARAP2 FAT4 FN1 APOB RUFY1 SYDE1 AK8 RIF1 IARS2 SF3B1 SLFN13 DOCK7 MPHOSPH9 RAPGEF2 SPEN PCDH7 CUX1	8.88e-11	777	194	23	35844135
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RAPGEF6 ABL2 LUZP1 ALMS1 PRRC2C NECTIN2 KMT2A DNMBP CNOT4 ARAP2 INTS12 OFD1 ARHGEF5 RFX7 CBL SYDE1 GRIP1 TET1 DOCK7 MPHOSPH9 SKA3 RAPGEF2 PCDH7 TP53BP2	1.14e-10	861	194	24	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 RAPGEF6 RPS6KA5 TATDN2 KMT2A DNMBP KDM6A FOXM1 PATL1 RFX7 GTF2IRD1 USP10 RIF1 PWWP2B SF3B1 TRIM28 RBM6 TRAPPC10 PKN2 CDK11B SPEN PCDH7	5.00e-10	774	194	22	15302935
Pubmed	[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	9.39e-10	4	194	4	18269867
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	VWA8 PRPF6 LUZP1 CLIC1 PRRC2C EIF2B4 UGDH CYB5R3 KMT2A DLAT C5 FN1 DDX52 ICAM1 APOB PATL1 LASP1 MSI1 UFM1 ARHGAP5 USP10 RIF1 SF3B1 DOCK7 CDK11B TRMT61A RBM17	1.37e-08	1371	194	27	36244648
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYLK NLRP7 NHSL2 ZBTB41 PRPF6 NDUFB4 LUZP1 PRRC2C CYB5R3 KMT2A DLAT MAP7D2 DLG2 TAF4 ITIH6 USP1 DNAH8 INTS12 DDX52 APOB RBM22 SF3B1 SPEN CEP57 ATP2B2 CUX1 ZNF292	3.87e-08	1442	194	27	35575683
Pubmed	Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.46e-08	8	194	4	20935224
Pubmed	A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.46e-08	8	194	4	15730517
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.16e-07	9	194	4	7749980
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NHSL2 LUZP1 PTPRN2 PRRC2C PPP1R3F DLG2 CDC73 TAF4 KCNT1 SYT3 USP28 USP10 SF3B1 TRIM28 SPHKAP DOCK7 PAK2 QSER1 RAPGEF2 CUX1 TP53BP2	1.20e-07	963	194	21	28671696
Pubmed	[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].	KIR2DL1 KIR2DL2 KIR2DL3	1.71e-07	3	194	3	19549382
Pubmed	Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.	KIR2DL1 KIR2DL3 KIR3DL1	1.71e-07	3	194	3	30698860
Pubmed	Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.	KIR2DL1 KIR2DL2 KIR2DL3	1.71e-07	3	194	3	15879158
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.92e-07	10	194	4	12559621
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	LUZP1 ALMS1 NFATC1 PRRC2C DNMBP FOXM1 INTS12 USP28 LASP1 RUFY1 RBM20 RBM22 YEATS4 RBM6 CDK11B SPEN	2.32e-07	588	194	16	38580884
Pubmed	Natural killer cells and immune surveillance.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	3.00e-07	11	194	4	18830515
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	3.00e-07	11	194	4	19664392
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	GGA2 ABL2 LUZP1 ALMS1 MAP7D2 DNMBP CNOT4 CDV3 OFD1 HUS1 PATL1 LASP1 RUFY1 GRIP1 ARHGAP5 IARS2 TMEM131 MPHOSPH9 TP53BP2	3.62e-07	853	194	19	28718761
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	4.49e-07	12	194	4	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	4.49e-07	12	194	4	19181658
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	4.49e-07	12	194	4	20371502
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.45e-07	13	194	4	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.45e-07	13	194	4	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.45e-07	13	194	4	18687225
Pubmed	Identification of molecules preferentially expressed beneath the marginal zone in the developing cerebral cortex.	RELN BCL6 CNTN2 FN1 CUX1	6.53e-07	30	194	5	18055048
Pubmed	B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.	KIR2DL1 KIR2DL2 KIR2DL3	6.81e-07	4	194	3	20056126
Pubmed	HLA-C and KIR genes in hepatitis C virus infection.	KIR2DL1 KIR2DL2 KIR2DL3	6.81e-07	4	194	3	16571411
Pubmed	NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.	KIR2DL1 KIR2DL3 KIR3DL1	6.81e-07	4	194	3	27732638
Pubmed	Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.	KIR2DL1 KIR2DL3 KIR3DL1	6.81e-07	4	194	3	18632158
Pubmed	Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.	KIR2DL1 KIR2DL2 KIR2DL3	6.81e-07	4	194	3	25037176
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2 KIR2DL3	6.81e-07	4	194	3	26542066
Pubmed	High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.	KIR2DL2 KIR2DL3 KIR3DL1	6.81e-07	4	194	3	19522772
Pubmed	[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].	KIR2DL1 KIR2DL2 KIR2DL3	6.81e-07	4	194	3	18543232
Pubmed	Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.	KIR2DL1 KIR2DL3 KIR3DL1	6.81e-07	4	194	3	23354323
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	8.99e-07	14	194	4	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	8.99e-07	14	194	4	19421224
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	8.99e-07	14	194	4	19489269
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	8.99e-07	14	194	4	15896204
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	17498266
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	20082646
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.22e-06	15	194	4	19326408
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RAPGEF6 ALMS1 CLIC1 PRRC2C CYB5R3 KMT2A CDV3 USP28 LASP1 USP10 RIF1 IARS2 SF3B1 TRIM28 PAK2 PKN2 SKA3 TP53BP2 RBM17	1.39e-06	934	194	19	33916271
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RAPGEF6 MARK1 LUZP1 ALMS1 OFD1 CBL GRIP1 USP10 DOCK7 TRAPPC10 MPHOSPH9 RAPGEF2 TP53BP2	1.53e-06	446	194	13	24255178
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	19897003
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	16403292
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	20652381
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	17868255
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	20331834
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	18668235
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	19527230
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	19279038
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	18643961
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.62e-06	16	194	4	20210919
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	ALMS1 MAP7D2 OFD1 DOCK7 MPHOSPH9 SKA3 CEP57	1.67e-06	101	194	7	24613305
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DL1 KIR2DL2 KIR2DL3	1.69e-06	5	194	3	18755860
Pubmed	Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.	KIR2DL1 KIR2DL2 KIR2DL3	1.69e-06	5	194	3	18322206
Pubmed	KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.	KIR2DL1 KIR2DL3 KIR3DL1	1.69e-06	5	194	3	27893413
Pubmed	Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.	KIR2DL1 KIR2DL3 KIR3DL1	1.69e-06	5	194	3	7716543
Pubmed	Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters.	KIR2DL1 KIR2DL2 KIR2DL3	1.69e-06	5	194	3	12121272
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DL1 KIR2DL2 KIR2DL3	1.69e-06	5	194	3	16112031
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	RIPOR2 FRMPD4 KDM6B ALMS1 PTPRN2 ZFYVE26 RAPGEF2	2.03e-06	104	194	7	9205841
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	20878400
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	19032228
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	20483367
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	19761533
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	20650299
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	20173792
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.11e-06	17	194	4	19169284
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.70e-06	18	194	4	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.70e-06	18	194	4	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.70e-06	18	194	4	19846535
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.70e-06	18	194	4	19630074
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.70e-06	18	194	4	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.70e-06	18	194	4	19046302
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.70e-06	18	194	4	20210918
Pubmed	Genomics and hearing impairment.	MYO7A MYO15A ATP2B2	3.38e-06	6	194	3	9927480
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	3.41e-06	19	194	4	20600442
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	3.41e-06	19	194	4	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	3.41e-06	19	194	4	18778326
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	3.41e-06	19	194	4	18848853
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	LUZP1 PRRC2C UGDH DNMBP CDV3 PATL1 LASP1 USP10 RBM22 DOCK7 PAK2 TMEM131 PKN2 SPEN ZNF292 RBM17	3.49e-06	724	194	16	36232890
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	4.24e-06	20	194	4	20193031
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	5.22e-06	21	194	4	19861144
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ILDR2 MYO7A MARK1 NDUFB4 LUZP1 PRRC2C SCN2A KMT2A DLAT MAP7D2 DLG2 CNTN2 FN1 SYT3 ARHGAP5 USP10 SF3B1 TRIM28 DOCK7 TRAPPC10 RAPGEF2 ATP2B2 TP53BP2	5.58e-06	1431	194	23	37142655
Pubmed	Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.	KIR2DL1 KIR2DL3 KIR3DL1	5.88e-06	7	194	3	12618911
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DL1 KIR2DL2 KIR3DL1	5.88e-06	7	194	3	14607943
Pubmed	Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.	KIR2DL1 KIR2DL3 KIR3DL1	5.88e-06	7	194	3	15748957
Interaction	YWHAH interactions	RAPGEF6 ABL2 NHSL2 MARK1 PRPF6 KCNK9 MTMR10 LUZP1 ALMS1 PRRC2C NECTIN2 KMT2A DNMBP CNOT4 ARAP2 INTS12 FN1 OFD1 ARHGEF5 RFX7 CBL SYDE1 GRIP1 IARS2 TET1 DOCK7 TRAPPC10 PAK2 MPHOSPH9 SKA3 RAPGEF2 TP53BP2	8.31e-09	1102	187	32	int:YWHAH
Interaction	WWTR1 interactions	RAPGEF6 LUZP1 ALMS1 NFATC1 PRRC2C KMT2A USP1 KDM6A CDV3 CBL RUFY1 USP10 YEATS4 DOCK7 PKN2 QSER1 SKA3 CUX1 TP53BP2	1.56e-08	422	187	19	int:WWTR1
Interaction	SFN interactions	RAPGEF6 ABL2 MARK1 KCNK9 LUZP1 ALMS1 PRRC2C KMT2A CDC73 DNMBP ARAP2 ARHGEF5 LASP1 CBL GRIP1 TRIM28 DOCK7 PAK2 PKN2 MPHOSPH9 SKA3 PCDH7 TP53BP2	1.24e-07	692	187	23	int:SFN
Interaction	YWHAQ interactions	RAPGEF6 ABL2 NLRP7 MARK1 KCNK9 LUZP1 NFATC1 NECTIN2 KMT2A CDC73 DNMBP CNOT4 ARAP2 FN1 HUS1 ARHGEF5 RFX7 CBL RUFY1 SYDE1 GRIP1 IARS2 TRIM28 TET1 DOCK7 MPHOSPH9 CDK11B RAPGEF2 PCDH7 TP53BP2	1.47e-07	1118	187	30	int:YWHAQ
Interaction	YWHAG interactions	RIPOR2 RAPGEF6 ABL2 NHSL2 MARK1 KCNK9 LUZP1 ALMS1 PRRC2C NECTIN2 KMT2A DNMBP CNOT4 ARAP2 FN1 ARHGEF5 RFX7 CBL SYDE1 GRIP1 IARS2 TET1 DOCK7 TRAPPC10 PAK2 PKN2 MPHOSPH9 CDK11B SKA3 RAPGEF2 PCDH7 TP53BP2	1.50e-07	1248	187	32	int:YWHAG
Interaction	YWHAE interactions	RAPGEF6 ABL2 MARK1 KCNK9 LUZP1 KMT2A CDC73 TAF4 DNMBP CNOT4 ARAP2 FN1 ARHGEF5 CBL RUFY1 SYDE1 GRIP1 IARS2 SF3B1 TRIM28 TET1 DOCK7 PAK2 MPHOSPH9 CDK11B RAPGEF2 CEP57 PCDH7 TP53BP2	5.00e-06	1256	187	29	int:YWHAE
Interaction	YWHAB interactions	RAPGEF6 ABL2 MARK1 PRPF6 KCNK9 LUZP1 NECTIN2 KMT2A CDC73 DNMBP CNOT4 ARAP2 FN1 ARHGEF5 RFX7 CBL SYDE1 GRIP1 DOCK7 TRAPPC10 PAK2 MPHOSPH9 CDK11B RAPGEF2 TP53BP2	7.99e-06	1014	187	25	int:YWHAB
Interaction	YWHAZ interactions	RIPOR2 RAPGEF6 ABL2 RPS6KA5 MARK1 KCNK9 MTMR10 LUZP1 NECTIN2 KMT2A DLAT CDC73 DNMBP ARAP2 FN1 ARHGEF5 CBL RUFY1 GRIP1 SF3B1 DOCK7 KCNK5 PAK2 MPHOSPH9 CDK11B RAPGEF2 ATP2B2 PCDH7 TP53BP2	1.27e-05	1319	187	29	int:YWHAZ
Cytoband	19q13.4	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 TRIM28	2.24e-05	79	194	5	19q13.4
Cytoband	5q33.1	FAT2 NDST1 RBM22	1.80e-04	26	194	3	5q33.1
Cytoband	1q41	MARK1 USH2A IARS2 TP53BP2	1.82e-04	66	194	4	1q41
Cytoband	Ensembl 112 genes in cytogenetic band chr1q41	MARK1 USH2A IARS2 TP53BP2	6.73e-04	93	194	4	chr1q41
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.38e-06	18	126	4	620
GeneFamily	Cadherin related	CDHR3 FAT2 FAT4	2.09e-04	17	126	3	24
GeneFamily	PDZ domain containing	RAPGEF6 FRMPD4 DLG2 CARD14 GRIP1 RAPGEF2	6.88e-04	152	126	6	1220
GeneFamily	RNA binding motif containing	CNOT4 MSI1 RBM20 RBM22 RBM6 SPEN RBM17	7.38e-04	213	126	7	725
GeneFamily	Fibronectin type III domain containing	MYLK INSRR USH2A CNTN2 IL31RA FN1	8.99e-04	160	126	6	555
Coexpression	KAYO_CALORIE_RESTRICTION_MUSCLE_UP	BCL6 CYB5R3 COL1A2 COL6A3 FN1 ATP2B2 CUX1	6.06e-06	94	192	7	M7013
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	PRRC2C TAF4 DNMBP CNOT4 DPYD RAB3GAP1 RBM6 TMEM131 PKN2 RAPGEF2 SPEN CUX1 TP53BP2 ZNF292	9.54e-06	466	192	14	M13522
Coexpression	VERRECCHIA_RESPONSE_TO_TGFB1_C2	COL1A2 COL6A3 FN1 ICAM1	1.51e-05	21	192	4	M4767
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2C	ILDR2 RELN MYLK FANCB ARAP2 NPNT FOXM1 EGR1 SKA3 ATP2B2 PCDH7	3.01e-05	325	192	11	M39053
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	RELN PRPF6 BNC1 CLIC1 COL1A2 FOXM1 TMEM248 HUS1 APOB LASP1 CBL UFM1 ARHGAP5 SPHKAP	3.14e-05	519	192	14	M3395
Coexpression	ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN	PRRC2C TAF4 LASP1 CBL ZNF341 SPEN	3.87e-05	85	192	6	M41085
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	ILDR2 BNC2 RIPOR2 GGA2 ABL2 MYLK NHSL2 KDM6B BNC1 CLIC1 PRRC2C KDM6A CNOT4 COL1A2 NDST1 DPYD MSI1 CBL ITIH5 ARHGAP5 RIF1 SF3B1 TET1 CEP57	9.57e-08	790	184	24	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	ILDR2 BNC2 GGA2 ABL2 NHSL2 KDM6B LUZP1 BNC1 CLIC1 PRRC2C KDM6A CNOT4 NPNT COL1A2 NDST1 MSI1 CBL ITIH5 RIF1 SF3B1 TET1 CEP57	1.83e-06	801	184	22	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	BNC2 ABL2 NHSL2 KDM6B BNC1 PRRC2C CNOT4 COL1A2 MSI1 CBL ITIH5 RIF1 SF3B1 TET1 CEP57	3.37e-06	413	184	15	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500	BNC2 ABHD3 PALMD IGSF10 BNC1 CFAP54 SEMA6D SHISA6 COL1A2 COL6A3 LRRN1 ITIH5 EGR1 KYAT3	4.81e-06	372	184	14	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	PRPF6 LUZP1 ALMS1 MAP7D2 USP1 DDX52 MPHOSPH9 CDK11B QSER1 RBM17	5.35e-06	186	184	10	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5	BNC2 NHSL2 PRPF6 PTGS1 LUZP1 IGSF10 COL1A2 DDX52 GTF2IRD1 EGR1 MPHOSPH9 QSER1 RBM17	6.71e-06	331	184	13	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	GPR155 BNC2 PRPF6 MTMR10 IGSF10 CFAP54 ALMS1 USP1 KDM6A CNOT4 COL1A2 INTS12 OFD1 SYT3 HUS1 ITIH5 ARHGAP5 RIF1 IARS2 TET1 OASL DOCK7 KYAT3 TMEM131 CDK11B QSER1 ZNF292	1.10e-05	1252	184	27	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	GPR155 ILDR2 BNC2 RIPOR2 ABL2 MYLK NHSL2 KDM6B PRRC2C KDM6A NPNT COL1A2 DPYD CBL UFM1 ITIH5 RIF1 SF3B1 TET1 CEP57	2.07e-05	797	184	20	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	BNC2 MARK1 ABHD3 PALMD IGSF10 BNC1 CFAP54 SEMA6D SCN2A UGDH KCNT1 SHISA6 COL1A2 COL6A3 FAT4 FN1 LRRN1 ITIH5 EGR1 KYAT3	2.07e-05	797	184	20	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	ILDR2 BNC2 RIPOR2 GGA2 ABL2 MYLK NHSL2 KDM6B CLIC1 PRRC2C KDM6A CNOT4 COL1A2 MSI1 CBL ITIH5 RIF1 SF3B1 TET1 CEP57	2.14e-05	799	184	20	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	ILDR2 BNC2 GGA2 ABL2 RPS6KA5 NHSL2 ABHD3 KDM6B BNC1 PRRC2C CDC73 KDM6A CNOT4 LRRN1 MSI1 RIF1 SF3B1 SPHKAP TET1 CEP57	2.34e-05	804	184	20	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	FILIP1 BNC2 MYLK MARK1 SYT17 BCL6 KDM6B BNC1 KLHL30 DNMBP ARAP2 FAT4 LRRN1 HUS1 IDE RBM20 PCDH7 MEGF10 CUX1 ZNF292	2.43e-05	806	184	20	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	BNC2 PRPF6 NDUFB4 PTGR3 LUZP1 IGSF10 ALMS1 PPP1R3F USP1 KDM6A CNOT4 COL1A2 INTS12 OFD1 HUS1 ARHGAP5 RIF1 IARS2 OASL DOCK7 KYAT3 CDK11B QSER1 CEP57 ZNF292 RBM17	2.66e-05	1241	184	26	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	ILDR2 BNC2 GGA2 ABL2 NHSL2 ABHD3 KDM6B BNC1 PRRC2C KDM6A CNOT4 LRRN1 MSI1 CBL RIF1 SF3B1 SPHKAP TET1 CEP57 MEGF10	2.84e-05	815	184	20	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500	ILDR2 ABL2 BNC1 KDM6A CNOT4	4.27e-05	45	184	5	gudmap_developingGonad_e16.5_epididymis_500_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	ILDR2 BNC2 IL13RA2 ABL2 RPS6KA5 ABHD3 KDM6B BNC1 ALMS1 MAP7D2 DNAH8 KDM6A CNOT4 LRRN1 OFD1 ARHGAP5 RIF1 SF3B1 CEP57	4.69e-05	776	184	19	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	ILDR2 BNC2 IL13RA2 ABL2 ABHD3 KDM6B BNC1 PRRC2C MAP7D2 KDM6A CNOT4 SHISA6 LRRN1 OFD1 ITIH5 ARHGAP5 RIF1 SF3B1 CEP57	4.85e-05	778	184	19	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	ILDR2 BNC2 ABL2 NHSL2 KDM6B BNC1 PRRC2C KDM6A CNOT4 COL1A2 ITIH5 SF3B1 TET1	5.69e-05	406	184	13	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	BNC2 ABL2 NHSL2 ABHD3 KDM6B BNC1 KDM6A CNOT4 MSI1 RIF1 SF3B1 SPHKAP CEP57	6.13e-05	409	184	13	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	LUZP1 ALMS1 PRRC2C RFX7 RIF1 TET1 RBM6 TMEM131 MPHOSPH9 CDK11B RAPGEF2 CEP57 ZNF292 RBM17	6.26e-05	469	184	14	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	ILDR2 BNC2 IL13RA2 ABL2 ABHD3 KDM6B BNC1 SEMA6D PRRC2C MAP7D2 DNAH8 KDM6A CNOT4 SHISA6 LRRN1 MSI1 ITIH5 RIF1 SF3B1	6.47e-05	795	184	19	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	ILDR2 LUZP1 ALMS1 PRRC2C MAP7D2 ITIH6 USP1 DDX52 PATL1 RFX7 RIF1 RBM6 MPHOSPH9 CEP57 RBM17	6.50e-05	532	184	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	BNC2 PRPF6 NDUFB4 PTGR3 LUZP1 IGSF10 ALMS1 PPP1R3F USP1 KDM6A CNOT4 COL1A2 INTS12 OFD1 HUS1 C10orf90 ARHGAP5 RIF1 IARS2 EGR1 OASL DOCK7 KYAT3 CDK11B QSER1 CEP57 ZNF292 RBM17	6.70e-05	1468	184	28	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	BNC2 ABL2 NHSL2 ABHD3 KDM6B BNC1 KDM6A MSI1 RIF1 SF3B1 SPHKAP CEP57 MEGF10	7.45e-05	417	184	13	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	alpha beta T cells, preT.ETP-2A.Th, Lin-/lo CD25int CD44+ cKit+, Thymus, avg-2	RPS6KA5 KDM6B IL31RA DENND3 CELSR1 TRIM28 TET1 DOCK7 KCNK5 QSER1 SKA3 RAPGEF2 CUX1	9.23e-05	426	184	13	GSM791152_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	PRPF6 LUZP1 SYT3 CTC1 GTF2IRD1 ARHGAP5 RIF1 EGR1 TET1 TMEM131 CDK11B QSER1 ZNF292	1.06e-04	432	184	13	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	BNC2 NHSL2 PRPF6 PTGS1 LUZP1 IGSF10 ALMS1 MAP7D2 DLG2 USP1 COL1A2 COL6A3 CDV3 LRRN1 DDX52 GTF2IRD1 EGR1 MPHOSPH9 CDK11B QSER1 RBM17	1.20e-04	978	184	21	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	ILDR2 BNC2 ABL2 ABHD3 KDM6B BNC1 PRRC2C MAP7D2 DNAH8 KDM6A CNOT4 SHISA6 LRRN1 OFD1 ITIH5 RIF1 SF3B1 CEP57	1.34e-04	770	184	18	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500	ILDR2 ABL2 ABHD3 BNC1 MAP7D2 KDM6A CNOT4 SHISA6 LRRN1 OFD1 ITIH5 RIF1	1.49e-04	387	184	12	gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	ILDR2 BNC2 ABL2 ABHD3 KDM6B BNC1 MAP7D2 KDM6A CNOT4 LRRN1 ITIH5 RIF1	1.49e-04	387	184	12	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	BNC2 RIPOR2 MYLK MARK1 PALMD IGSF10 BNC1 UGDH COL1A2 FOXM1 COL6A3 FN1 ITIH5 EGR1 SLFN13 TET1 QSER1 CUX1	1.50e-04	777	184	18	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_1000	ILDR2 ABL2 MAP7D2 DNAH8 SHISA6 ITIH5	1.59e-04	93	184	6	gudmap_developingGonad_e16.5_ovary_1000_k3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_500	BNC2 NHSL2 ABHD3 RIF1 SF3B1	1.72e-04	60	184	5	gudmap_developingGonad_e12.5_ovary_k4_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000	BNC2 NHSL2 LUZP1 NDST1 CBL ITIH5 RIF1 SF3B1	2.09e-04	184	184	8	gudmap_developingGonad_e14.5_ epididymis_1000_k2
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	ILDR2 BNC2 RIPOR2 ABL2 NHSL2 KDM6B PRRC2C CNOT4 COL1A2 ITIH5 TET1 CEP57	2.21e-04	404	184	12	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ILDR2 PRPF6 LUZP1 ALMS1 MAP7D2 RIF1 MPHOSPH9 CDK11B	2.78e-04	192	184	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	GPR155 RPS6KA5 ZBTB41 BCL6 BNC1 NFATC1 CDC73 KDM6A LRRN1 RFX7 RBM20 RIF1 SF3B1	2.85e-04	478	184	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500	BNC2 ABHD3 PALMD IGSF10 SEMA6D COL1A2 COL6A3 FAT4 LRRN1 EGR1 KYAT3	2.96e-04	357	184	11	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500	ZBTB41 BCL6 BNC1 NFATC1 LRRN1 RFX7 RIF1 PRKG2 MEGF10	3.35e-04	249	184	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500	ZBTB41 BCL6 BNC1 FAT2 NFATC1 NPNT LRRN1 RFX7 RIF1 PRKG2 MEGF10 CUX1	3.72e-04	428	184	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	PRPF6 LUZP1 ALMS1 MAP7D2 USP1 CDV3 DDX52 GTF2IRD1 EGR1 MPHOSPH9 CDK11B QSER1 RBM17	3.76e-04	492	184	13	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#2	BNC2 SHISA6 COL1A2 COL6A3 FN1 LRRN1 ITIH5 MEGF10	3.79e-04	201	184	8	Arv_EB-LF_1000_K2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000	MARK1 BNC1 FOXM1 FN1 TET1	3.79e-04	71	184	5	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	PRPF6 LUZP1 ALMS1 KDM6A GTF2IRD1 RIF1 MPHOSPH9 CDK11B CUX1 ZNF292	3.99e-04	311	184	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_500	BNC2 ABHD3 KDM6B ITIH5 RIF1	4.05e-04	72	184	5	gudmap_developingGonad_e16.5_ovary_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	GPR155 RPS6KA5 ZBTB41 BCL6 BNC1 FAT2 NFATC1 CDC73 KDM6A NPNT LRRN1 RFX7 RBM20 RIF1 SF3B1 PRKG2 MEGF10 CUX1	4.42e-04	850	184	18	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	ILDR2 ALMS1 PRRC2C MAP7D2 LRRN1 TET1 RBM6 CDK11B RBM17	4.46e-04	259	184	9	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500	ILDR2 ABL2 BNC1 MAP7D2 DNAH8 KDM6A SHISA6 LRRN1 OFD1 ITIH5 RIF1	4.90e-04	379	184	11	gudmap_developingGonad_P2_ovary_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	BNC2 PALMD IGSF10 SCN2A UGDH COL1A2 COL6A3 ITIH5 EGR1	5.26e-04	265	184	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	ILDR2 GGA2 NHSL2 PRRC2C KDM6A CNOT4 MSI1 SF3B1 TET1 CEP57	5.36e-04	323	184	10	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	BNC2 ABHD3 PALMD IGSF10 BNC1 SEMA6D UGDH KCNT1 SHISA6 COL1A2 COL6A3 FAT4 FN1 LRRN1 EGR1 KYAT3 PCDH7	5.90e-04	797	184	17	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	BNC2 RIPOR2 ABL2 NHSL2 ABHD3 KDM6B BNC1 PRRC2C KDM6A CNOT4 MSI1 CBL RIF1 SF3B1 TET1 RBM6 CEP57	6.68e-04	806	184	17	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500	BNC2 PALMD IGSF10 COL1A2 COL6A3 EGR1	6.87e-04	122	184	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_500	ILDR2 MAP7D2 SHISA6 OFD1 ITIH5	6.96e-04	81	184	5	gudmap_developingGonad_e18.5_ovary_500_k4
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	RIPOR2 RAPGEF6 PRRC2C KMT2A DNAH8 USP28 RIF1 SLFN13 TET1 ZNF292	7.27e-04	336	184	10	GSM538413_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	BNC2 RIPOR2 MYLK ZBTB41 IGSF10 COL1A2 COL6A3 ITIH5 EGR1 SLFN13	7.27e-04	336	184	10	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	BNC2 ABHD3 PALMD IGSF10 SEMA6D SCN2A UGDH KDM6A KCNT1 COL1A2 COL6A3 FAT4 LRRN1 ITIH5 EGR1 KYAT3	7.41e-04	740	184	16	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000	BNC2 NHSL2 KDM6B NDST1 RIF1 SF3B1	7.48e-04	124	184	6	gudmap_developingGonad_e16.5_epididymis_1000_k1
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	ZBTB41 PRRC2C DNMBP CNOT4 LASP1 IDE RIF1 PKN2 PCDH7 CUX1	7.78e-04	339	184	10	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000	ILDR2 ABL2 BNC1 KDM6A CNOT4 ARHGAP5	8.48e-04	127	184	6	gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlas	AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000	ILDR2 BNC2 RELN ENKUR CYTL1 IGSF10 AHSG CNTN2 SHISA6 ARAP2 NPNT COL1A2 COL6A3 FN1 LRRN1 APOB ITIH5 SLC11A1 MEGF10	9.02e-04	981	184	19	Arv_EB-LF_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	RELN RIPOR2 MARK1 SYT17 CFAP54 ALMS1 USP1 INTS12 LRRN1 USP28 MSI1 CPT1B GRIP1 ARHGAP5 RIF1 IARS2 DOCK7 CDK11B QSER1 ZNF292	9.09e-04	1060	184	20	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100	BNC1 EGR1 SPHKAP MEGF10 CUX1	9.14e-04	86	184	5	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ILDR2 ZBTB41 PRPF6 LUZP1 ALMS1 MAP7D2 KDM6A CNOT4 LRRN1 GTF2IRD1 GRIP1 RIF1 MPHOSPH9 CDK11B CCDC181 CUX1 ZNF292	9.35e-04	831	184	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500	RIPOR2 COL1A2 COL6A3 FN1 ITIH5 SLFN13	9.58e-04	130	184	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000	ILDR2 IL13RA2 MAP7D2 DNAH8 LRRN1 OFD1 RIF1	9.72e-04	179	184	7	gudmap_developingGonad_e14.5_ ovary_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	BNC2 NHSL2 PRPF6 PTGS1 LUZP1 IGSF10 USP1 COL1A2 FAT4 SYT3 DDX52 GTF2IRD1 EGR1 MPHOSPH9 CDK11B QSER1 RBM17	9.73e-04	834	184	17	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000	ILDR2 BNC1 CDC73 KDM6A CNOT4 LRRN1 RIF1 SF3B1	9.97e-04	233	184	8	gudmap_developingGonad_e12.5_ovary_k5_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500	BNC2 NHSL2 CBL RIF1 SF3B1	1.18e-03	91	184	5	gudmap_developingGonad_e14.5_ epididymis_500_k5
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000	BNC2 NHSL2 KDM6B CBL RIF1 SF3B1	1.21e-03	136	184	6	gudmap_developingGonad_P2_epididymis_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#4_top-relative-expression-ranked_500	SYT17 EGR1 CUX1 ZNF292	1.23e-03	54	184	4	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	BNC2 ZBTB41 BCL6 BNC1 NFATC1 LRRN1 RFX7 RBM20 RIF1 SF3B1 MEGF10 ZNF292	1.26e-03	492	184	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FILIP1 BNC2 MYLK COL1A2 COL6A3 DPYD FAT4 FN1 ITIH5 PKN2 PCDH7	1.11e-09	196	194	11	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BNC2 MYLK NPNT COL1A2 CASS4 DPYD FN1 ITIH5 PKN2 PCDH7	1.39e-08	193	194	10	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BNC2 MYLK NPNT COL1A2 CASS4 DPYD FN1 ITIH5 PKN2 PCDH7	1.46e-08	194	194	10	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FILIP1 BNC2 MYLK IGSF10 COL1A2 COL6A3 DPYD FN1 PKN2 PCDH7	1.68e-08	197	194	10	31a1852911bda38543916585fda34255fd62a134
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FILIP1 MYLK IGSF10 COL1A2 COL6A3 DPYD FN1 SPHKAP PKN2 PCDH7	1.68e-08	197	194	10	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 MYLK COL1A2 COL6A3 DPYD FAT4 FN1 ITIH5 SPHKAP PCDH7	1.68e-08	197	194	10	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	BNC2 MYLK DLG2 NPNT COL1A2 CASS4 COL6A3 FAT4 FN1 PCDH7	1.68e-08	197	194	10	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 BNC2 MYLK COL1A2 COL6A3 DPYD FAT4 FN1 ITIH5 PCDH7	1.77e-08	198	194	10	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	GPR155 RELN CYTL1 XKR4 SEMA6D ARAP2 RASGEF1C KCNK5 MEGF10	7.21e-08	173	194	9	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 PALMD LUZP1 PRRC2C CNOT4 ARAP2 ARHGAP5 PAK2 PKN2	9.20e-08	178	194	9	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	RA-16._Neuronal\|RA / Chamber and Cluster_Paper	GPR155 RELN XKR4 ARAP2 NPNT ITIH5 RASGEF1C KCNK5 MEGF10	1.01e-07	180	194	9	5842febfdabac61ce970254fb0ef17a628f1b8c0
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 MYLK NHSL2 IGSF10 COL1A2 CASS4 COL6A3 FN1 PCDH7	1.06e-07	181	194	9	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ILDR2 BNC2 MYLK NPNT COL1A2 COL6A3 FAT4 FN1 APOB	1.06e-07	181	194	9	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN FRMPD4 SCN2A USH2A DNAH5 CNTN2 FAT4 APOB MYO15A	1.22e-07	184	194	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN FRMPD4 SCN2A USH2A DNAH5 CNTN2 FAT4 APOB MYO15A	1.22e-07	184	194	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN FRMPD4 SCN2A USH2A DNAH5 CNTN2 FAT4 APOB MYO15A	1.22e-07	184	194	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PALMD KDM6B LUZP1 PRRC2C CNOT4 ARHGAP5 SF3B1 EGR1 PKN2	1.47e-07	188	194	9	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BNC2 MYLK IGSF10 NPNT COL6A3 FN1 ITIH5 PKN2 PCDH7	1.53e-07	189	194	9	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	BNC2 MYLK NHSL2 COL1A2 CASS4 COL6A3 FAT4 FN1 PCDH7	1.83e-07	193	194	9	acad568621ed677031797b8c2e34dafea798d681
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 MYLK COL1A2 COL6A3 DPYD FAT4 FN1 PKN2 PCDH7	2.00e-07	195	194	9	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FILIP1 BNC2 NHSL2 COL1A2 COL6A3 FAT4 FN1 ITIH5 SLC14A2	2.18e-07	197	194	9	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 MYLK NHSL2 COL1A2 CASS4 COL6A3 FN1 ITIH5 PCDH7	2.48e-07	200	194	9	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	GPR155 RELN XKR4 ARAP2 NPNT RASGEF1C KCNK5 MEGF10	6.66e-07	165	194	8	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MYO7A DNMBP CTC1 USP28 CELSR1 ZNF341 PCDH7	7.29e-07	167	194	8	961e722442d786ab15d1e490941d2be265a9057a
ToppCell	facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MYO7A DNMBP CTC1 USP28 CELSR1 ZNF341 PCDH7	7.29e-07	167	194	8	3760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCell	367C-Fibroblasts-Fibroblast-G-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IL13RA2 SYT17 SEMA6D NPNT COL1A2 COL6A3 FN1 APOB	7.63e-07	168	194	8	b8c65542a0701ae31f49d332d87a64578e24b4e3
ToppCell	367C-Fibroblasts-Fibroblast-G\|367C / Donor, Lineage, Cell class and subclass (all cells)	IL13RA2 SYT17 SEMA6D NPNT COL1A2 COL6A3 FN1 APOB	7.63e-07	168	194	8	8c95093b1ea45826f62893edd3c410fe53b563a4
ToppCell	LV-16._Neuronal\|LV / Chamber and Cluster_Paper	GPR155 RELN XKR4 ARAP2 NPNT RASGEF1C KCNK5 MEGF10	7.98e-07	169	194	8	a8fc8ab0f0757e939e213efb61c03cfe390bf7d2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NHSL2 IGSF10 NFATC1 COL1A2 COL6A3 FAT4 FN1 PCDH7	1.08e-06	176	194	8	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRPF6 IGSF10 PRRC2C KDM6A RBM20 ARHGAP5 PKN2 PCDH7	1.08e-06	176	194	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NHSL2 IGSF10 NFATC1 COL1A2 COL6A3 FAT4 FN1 PCDH7	1.08e-06	176	194	8	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	RA-16._Neuronal\|World / Chamber and Cluster_Paper	GPR155 RELN XKR4 ARAP2 NPNT RASGEF1C KCNK5 MEGF10	1.34e-06	181	194	8	7d22a43f887e0747f0cb87ba364ff27905ee6eec
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MYLK UGDH NPNT COL1A2 COL6A3 FAT4 FN1 PRKG2	1.39e-06	182	194	8	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	BNC2 MYLK NHSL2 COL1A2 CASS4 COL6A3 FN1 EGR1	1.71e-06	187	194	8	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	BNC2 MYLK MARK1 COL1A2 COL6A3 FAT4 FN1 ITIH5	1.71e-06	187	194	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	BNC2 MYLK DLG2 COL1A2 COL6A3 FN1 RBM20 PCDH7	1.71e-06	187	194	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	MYLK UGDH NPNT COL1A2 CASS4 COL6A3 FN1 PRKG2	1.78e-06	188	194	8	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARK1 IGSF10 FAM229B MAP7D2 COL1A2 COL6A3 DPYD MEGF10	1.85e-06	189	194	8	6e83bf855d4771885b60bb8992df2f9b508eef97
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARK1 IGSF10 FAM229B MAP7D2 COL1A2 COL6A3 DPYD MEGF10	1.85e-06	189	194	8	cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARK1 IGSF10 FAM229B MAP7D2 COL1A2 COL6A3 DPYD MEGF10	1.85e-06	189	194	8	102501eee7760d5882dec41ea9d00147b3f4fb73
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BNC2 CLIC1 KIR2DL1 KIR2DL3 KIR3DL1 ARAP2 USP28 SLFN13	1.92e-06	190	194	8	1f890be1ac8613a098b271945f25a58c3c2530ab
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BNC2 CLIC1 KIR2DL1 KIR2DL3 KIR3DL1 ARAP2 USP28 SLFN13	1.92e-06	190	194	8	d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	IL13RA2 MYLK NPNT CASS4 COL6A3 FN1 ITIH5 PKN2	1.92e-06	190	194	8	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FILIP1 BNC2 COL1A2 DPYD FN1 ITIH5 PKN2 PCDH7	2.00e-06	191	194	8	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 MYLK NHSL2 NPNT COL1A2 COL6A3 FAT4 PCDH7	2.00e-06	191	194	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYLK UGDH NPNT COL1A2 CASS4 COL6A3 FN1 EGR1	2.08e-06	192	194	8	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MTMR10 PTGS1 SCN2A DLG2 NPNT GRIP1 SLC14A2 PCDH7	2.08e-06	192	194	8	0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYLK UGDH NPNT COL1A2 CASS4 COL6A3 FN1 EGR1	2.08e-06	192	194	8	e79f2253e084a9ab9afcaf7ec42a5012ade42d36
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYLK DLG2 NPNT CASS4 COL6A3 INTS12 FN1 PCDH7	2.08e-06	192	194	8	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MYLK ABHD3 LUZP1 NECTIN2 COL6A3 ICAM1 EGR1 PCDH7	2.16e-06	193	194	8	cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FILIP1 IGSF10 AHSG DLG2 COL1A2 COL6A3 ITIH5 PRKG2	2.16e-06	193	194	8	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 MYLK NHSL2 COL1A2 CASS4 COL6A3 FN1 PCDH7	2.16e-06	193	194	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 FRMPD4 MYLK IGSF10 DLG2 COL1A2 COL6A3 PCDH7	2.24e-06	194	194	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 LUZP1 PRRC2C CNOT4 COL1A2 ARHGAP5 PAK2 PKN2	2.24e-06	194	194	8	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IL13RA2 MYLK IGSF10 NPNT COL1A2 COL6A3 FN1 ITIH5	2.24e-06	194	194	8	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	BNC2 MYLK NHSL2 DLG2 COL1A2 COL6A3 FN1 ITIH5	2.33e-06	195	194	8	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FILIP1 ABL2 BCL6 KDM6B COL1A2 COL6A3 ICAM1 EGR1	2.33e-06	195	194	8	fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 RELN INSRR PTPRN2 PRRC2C KMT2A RIF1 SPHKAP	2.33e-06	195	194	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 RELN INSRR PTPRN2 PRRC2C KMT2A RIF1 SPHKAP	2.33e-06	195	194	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK UGDH NPNT COL1A2 CASS4 COL6A3 FN1 PRKG2	2.42e-06	196	194	8	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 MYLK NHSL2 IGSF10 COL1A2 COL6A3 FN1 PCDH7	2.42e-06	196	194	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 CYTL1 PTGS1 NECTIN2 AHSG ICAM1 CELSR1 PCDH7	2.42e-06	196	194	8	dbf154b3d166ffd07be717dac8d8a3350ac63e16
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 CYTL1 PTGS1 NECTIN2 AHSG ICAM1 CELSR1 PCDH7	2.42e-06	196	194	8	7d5eaed189aa6116f3799be010139fb675ec65e0
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 MYLK NHSL2 INSRR COL1A2 COL6A3 FAT4 ITIH5	2.51e-06	197	194	8	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 MYLK MARK1 CDHR3 COL1A2 COL6A3 FAT4 FN1	2.51e-06	197	194	8	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK IGSF10 NPNT COL1A2 COL6A3 FAT4 FN1 EGR1	2.51e-06	197	194	8	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	BNC2 MYLK NHSL2 DLG2 COL1A2 COL6A3 FN1 PCDH7	2.51e-06	197	194	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FILIP1 BNC2 MYLK COL1A2 COL6A3 FAT4 FN1 PCDH7	2.51e-06	197	194	8	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BNC2 NLRP7 KIR2DL1 KIR2DL3 KIR3DL1 FAT4 USP28 SLFN13	2.51e-06	197	194	8	bc37b8919f98dc18c2200834405f06823d965d78
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	BNC2 MYLK NHSL2 DLG2 COL1A2 COL6A3 FN1 PCDH7	2.51e-06	197	194	8	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	FILIP1 IL13RA2 MYLK IGSF10 NPNT COL1A2 COL6A3 ITIH5	2.61e-06	198	194	8	a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	FILIP1 IL13RA2 MYLK IGSF10 NPNT COL1A2 COL6A3 ITIH5	2.61e-06	198	194	8	7b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MYLK SEMA6D COL1A2 COL6A3 FAT4 FN1 ITIH5 PCDH7	2.71e-06	199	194	8	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	VWA8 DLG2 KDM6A DPYD RFX7 GRIP1 RBM6 RAPGEF2	2.71e-06	199	194	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 BNC2 MYLK COL1A2 COL6A3 FAT4 FN1 PCDH7	2.71e-06	199	194	8	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RELN FRMPD4 SCN2A MAP7D2 KCNT1 SYT3 GRIP1 SPHKAP	2.81e-06	200	194	8	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK MYO7A IGSF10 COL1A2 CASS4 COL6A3 FN1 ITIH5	2.81e-06	200	194	8	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RELN FRMPD4 SCN2A MAP7D2 KCNT1 SYT3 GRIP1 SPHKAP	2.81e-06	200	194	8	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYLK IGSF10 NPNT COL1A2 CASS4 COL6A3 FAT4 PCDH7	2.81e-06	200	194	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PRRC2C KMT2A ARAP2 CDV3 SF3B1 OASL PKN2 ZNF292	2.81e-06	200	194	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK IGSF10 NPNT COL1A2 CASS4 COL6A3 FAT4 PCDH7	2.81e-06	200	194	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	RIPOR2 PRRC2C KMT2A ARAP2 CDV3 SF3B1 OASL PAK2	2.81e-06	200	194	8	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 MYLK NHSL2 COL1A2 CASS4 COL6A3 FN1 PCDH7	2.81e-06	200	194	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 MYLK NHSL2 COL1A2 CASS4 COL6A3 FN1 PCDH7	2.81e-06	200	194	8	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RELN FRMPD4 SCN2A MAP7D2 KCNT1 SYT3 GRIP1 SPHKAP	2.81e-06	200	194	8	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 MYLK NHSL2 COL1A2 CASS4 COL6A3 FN1 PCDH7	2.81e-06	200	194	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK MYO7A IGSF10 COL1A2 CASS4 COL6A3 FN1 ITIH5	2.81e-06	200	194	8	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK IGSF10 NPNT COL1A2 CASS4 COL6A3 FAT4 PCDH7	2.81e-06	200	194	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	BNC2 IL13RA2 ABL2 COL1A2 COL6A3 IL31RA ITIH5	6.38e-06	159	194	7	92049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 MYLK MARK1 COL1A2 FAT4 FN1 PCDH7	7.81e-06	164	194	7	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	CYTL1 CFAP54 COL1A2 COL6A3 IL31RA LRRN1 PCDH7	7.81e-06	164	194	7	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GPR155 RELN CYTL1 XKR4 SEMA6D RASGEF1C MEGF10	9.14e-06	168	194	7	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	LA-16._Neuronal\|World / Chamber and Cluster_Paper	GPR155 RELN XKR4 ARAP2 RASGEF1C KCNK5 MEGF10	9.14e-06	168	194	7	2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MTMR10 SERGEF COL1A2 COL6A3 DPYD FN1 MEGF10	9.88e-06	170	194	7	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	NS-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BNC2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 SLFN13 MPHOSPH9	1.03e-05	171	194	7	adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	BNC2 NLRP7 MYO7A KIR2DL1 KIR2DL3 KIR3DL1 SLFN13	1.07e-05	172	194	7	e3a8891694343b6b01e80a200ae338d24797e417
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYLK PALMD KIAA1210 COL1A2 COL6A3 ADAM32 PCDH7	1.28e-05	177	194	7	cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYLK PALMD KIAA1210 COL1A2 COL6A3 ADAM32 PCDH7	1.28e-05	177	194	7	db222faaecbe5600da39277243c4e7e764eb63c9
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SYT17 COL1A2 COL6A3 LRRN1 SPHKAP PCDH7	1.38e-05	179	194	7	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BNC2 COL1A2 COL6A3 FAT4 FN1 ITIH5 PCDH7	1.43e-05	180	194	7	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
Disease	MYELODYSPLASTIC SYNDROME	FANCB CTC1 CBL SF3B1 CUX1	6.81e-05	67	187	5	C3463824
Disease	level of killer cell immunoglobulin-like receptor 2DS2 in blood serum	KIR2DL1 KIR2DL3	1.19e-04	3	187	2	OBA_2042107
Disease	angiopoietin-related protein 3 measurement	USP1 DOCK7	1.19e-04	3	187	2	EFO_0020148
Disease	Usher syndrome type 2	MYO7A USH2A	1.19e-04	3	187	2	C0339534
Disease	Leukemia, Myelocytic, Acute	FANCB NECTIN2 KMT2A CTC1 CBL SF3B1 CUX1	1.23e-04	173	187	7	C0023467
Disease	atrial fibrillation	FILIP1 CDHR3 PALMD NFATC1 RBM20 PAK2 PKN2 SPEN DCAF4 ZNF292	1.38e-04	371	187	10	EFO_0000275
Disease	ureteral obstruction (biomarker_via_orthology)	COL1A2 FN1 ICAM1 PAK2	1.90e-04	45	187	4	DOID:5199 (biomarker_via_orthology)
Disease	Usher syndrome (is_implicated_in)	MYO7A USH2A	2.38e-04	4	187	2	DOID:0050439 (is_implicated_in)
Disease	schizophrenia, anorexia nervosa	SEMA6D ALMS1 DLG2 MPHOSPH9	2.44e-04	48	187	4	MONDO_0005090, MONDO_0005351
Disease	Alzheimer disease	RELN RAPGEF6 CDHR3 PRRC2C NECTIN2 CASS4 DENND3 RASGEF1C MYO15A PCDH7 MEGF10	2.87e-04	485	187	11	MONDO_0004975
Disease	schizophrenia, intelligence, self reported educational attainment	SEMA6D PTPRN2 KMT2A CNOT4 DPYD SF3B1 SPHKAP RBM6 MPHOSPH9	3.86e-04	346	187	9	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	diet measurement	ILDR2 BNC2 SYT17 DCAF16 SEMA6D SCN2A NECTIN2 DLG2 DNAH5 POU2F3 CNOT4 SHISA6 DPYD APOB RBM6 KCNK5 PCDH7	3.93e-04	1049	187	17	EFO_0008111
Disease	Usher Syndrome, Type II	MYO7A USH2A	3.95e-04	5	187	2	C1568249
Disease	chronic obstructive pulmonary disease	BNC2 DLG2 DNAH5 ARAP2 NPNT COL6A3 DPYD INTS12 RASGEF1C MPHOSPH9 QSER1 SLC14A2 DCAF4	4.75e-04	688	187	13	EFO_0000341
Disease	bilirubin measurement	BCL6 PTGR3 NECTIN2 CYB5R3 DNMBP FAT4 APOB DOCK7 PAK2 PKN2	5.52e-04	442	187	10	EFO_0004570
Disease	Acute monocytic leukemia	FANCB KMT2A CTC1	5.85e-04	26	187	3	C0023465
Disease	diabetic angiopathy (implicated_via_orthology)	FN1 ICAM1	5.89e-04	6	187	2	DOID:11713 (implicated_via_orthology)
Disease	severe acute respiratory syndrome, COVID-19	RELN FRMPD4 MYO7A OR2Z1 COL6A3 C10orf90 GRIP1 YEATS4 CDK11B CEP57	6.02e-04	447	187	10	EFO_0000694, MONDO_0100096
Disease	Ciliopathies	MYO7A USH2A DNAH5 DNAH8 OFD1	6.93e-04	110	187	5	C4277690
Disease	cortical thickness	BNC2 RELN RIPOR2 LUZP1 BNC1 KMT2A RUFY1 DENND3 ITIH5 GRIP1 CELSR1 SF3B1 DOCK7 RASGEF1C TMEM131 QSER1 PCDH7	7.61e-04	1113	187	17	EFO_0004840
Disease	cortical surface area measurement	ILDR2 FILIP1 BNC2 RELN LUZP1 PRRC2C CNOT4 DENND3 ITIH5 GRIP1 CELSR1 SF3B1 RASGEF1C PKN2 MPHOSPH9 QSER1 PCDH7 CUX1 TRMT61A	9.51e-04	1345	187	19	EFO_0010736
Disease	diffuse large B-cell lymphoma (is_marker_for)	BCL6 ICAM1	1.09e-03	8	187	2	DOID:0050745 (is_marker_for)
Disease	renovascular hypertension (implicated_via_orthology)	PTGS1 FN1	1.40e-03	9	187	2	DOID:1591 (implicated_via_orthology)
Disease	1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement	USP1 DOCK7	1.40e-03	9	187	2	EFO_0800439
Disease	Nonsyndromic genetic hearing loss	RIPOR2 MYO7A MYO15A ATP2B2	1.40e-03	76	187	4	cv:C5680182
Disease	Autistic Disorder	GPR155 RELN VWA8 MARK1 DPYD LASP1 ZNF292	1.44e-03	261	187	7	C0004352
Disease	cholesteryl esters to total lipids in very large HDL percentage	NECTIN2 APOB DOCK7	1.53e-03	36	187	3	EFO_0022257
Disease	cholesteryl esters to total lipids in medium LDL percentage	NECTIN2 APOB DOCK7	1.66e-03	37	187	3	EFO_0022252
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	BNC2 BNC1 SEMA6D ALMS1 PTPRN2 SCN2A DLG2 USH2A ARAP2 USP28 SLC14A2 PCDH7 CUX1	1.88e-03	801	187	13	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	3-hydroxy-1-methylpropylmercapturic acid measurement	NHSL2 SYT17 KIAA1210 NFATC1 PTPRN2 DPYD PWWP2B PCDH7	1.91e-03	352	187	8	EFO_0007015
Disease	Hypercholesterolemia	MYLK ICAM1 APOB	1.94e-03	39	187	3	C0020443
Disease	aortic valve stenosis (is_marker_for)	NFATC1 EGR1	2.12e-03	11	187	2	DOID:1712 (is_marker_for)
Disease	response to radiation, breast carcinoma	SEMA6D PTPRN2	2.12e-03	11	187	2	EFO_0000305, GO_0009314
Disease	3-hydroxyanthranilate 3,4-dioxygenase measurement	DNMBP CPN2	2.12e-03	11	187	2	EFO_0021862
Disease	osteosarcoma (is_marker_for)	CBL EGR1	2.12e-03	11	187	2	DOID:3347 (is_marker_for)
Disease	Autism Spectrum Disorders	RELN USH2A DPYD TET1	2.12e-03	85	187	4	C1510586
Disease	diabetes mellitus (is_marker_for)	FN1 ICAM1 APOB	2.24e-03	41	187	3	DOID:9351 (is_marker_for)
Disease	sleep duration	RELN SEMA6D KMT2A SHISA6 NPNT DPYD CTC1 PRKG2	2.27e-03	362	187	8	EFO_0005271
Disease	Disorder of eye	MYO7A PRPF6 ALMS1 USH2A OFD1 GRIP1	2.39e-03	212	187	6	C0015397
Disease	Hereditary hearing loss and deafness	RIPOR2 MYO7A DLAT MYO15A ATP2B2	2.43e-03	146	187	5	cv:C0236038
Disease	protein CEI measurement	USP1 DOCK7	2.53e-03	12	187	2	EFO_0801936
Disease	Bronchial Hyperreactivity	PTGS1 ICAM1	2.53e-03	12	187	2	C0085129
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A SF3B1	2.53e-03	12	187	2	DOID:9119 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in small HDL percentage	NECTIN2 APOB DOCK7	2.57e-03	43	187	3	EFO_0022254
Disease	Malignant Head and Neck Neoplasm	FANCB CDC73 DPYD	2.74e-03	44	187	3	C0278996
Disease	cholesterol in medium VLDL measurement	NECTIN2 APOB DOCK7	2.74e-03	44	187	3	EFO_0022225
Disease	Multiple Sclerosis	NECTIN2 ICAM1 SLC11A1	2.92e-03	45	187	3	C0026769
Disease	Multiple Sclerosis, Acute Fulminating	NECTIN2 ICAM1 SLC11A1	2.92e-03	45	187	3	C0751324
Disease	Modic type vertebral endplate changes	XKR4 DLG2	2.98e-03	13	187	2	HP_0030775
Disease	Infantile Severe Myoclonic Epilepsy	SCN2A RAPGEF2	2.98e-03	13	187	2	C0751122
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	USP1 DOCK7	2.98e-03	13	187	2	OBA_2045159
Disease	pre-eclampsia (implicated_via_orthology)	PTGS1 ICAM1	2.98e-03	13	187	2	DOID:10591 (implicated_via_orthology)
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	NECTIN2 AHSG USP1 APOB DOCK7	2.98e-03	153	187	5	EFO_0004611, EFO_0020946
Disease	osteoarthritis	RELN MYLK XKR4 DLG2 RBM6 MPHOSPH9	3.01e-03	222	187	6	MONDO_0005178
Disease	Squamous cell carcinoma of esophagus	FAT2 CLIC1 KDM6A FAT4	3.17e-03	95	187	4	C0279626
Disease	free cholesterol in small VLDL measurement	NECTIN2 APOB DOCK7	3.31e-03	47	187	3	EFO_0022272
Disease	free cholesterol in medium VLDL measurement	NECTIN2 APOB DOCK7	3.31e-03	47	187	3	EFO_0022269
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	EIF2B4 DPYD	3.46e-03	14	187	2	C1858991
Disease	triacylglycerol 52:1 measurement	RIPOR2 NFATC1	3.46e-03	14	187	2	EFO_0010413
Disease	Malignant neoplasm of breast	PTGS1 CLIC1 NECTIN2 MAP7D2 FOXM1 DPYD FN1 SYT3 MSI1 RUFY1 RIF1 ZFYVE26 SPEN CUX1 TP53BP2	3.62e-03	1074	187	15	C0006142
Disease	Acute Confusional Senile Dementia	RELN NECTIN2 CASS4 IDE	3.68e-03	99	187	4	C0546126
Disease	Alzheimer's Disease, Focal Onset	RELN NECTIN2 CASS4 IDE	3.68e-03	99	187	4	C0750900
Disease	Alzheimer Disease, Early Onset	RELN NECTIN2 CASS4 IDE	3.68e-03	99	187	4	C0750901
Disease	Presenile dementia	RELN NECTIN2 CASS4 IDE	3.68e-03	99	187	4	C0011265
Disease	Alzheimer Disease, Late Onset	RELN NECTIN2 CASS4 IDE	3.68e-03	99	187	4	C0494463
Disease	response to bronchodilator, FEV/FEC ratio	BNC2 RIPOR2 MYO7A FAT2 SEMA6D DLG2 DNAH5 NPNT ARHGEF5 DENND3 GRIP1 PCDH7	3.70e-03	766	187	12	EFO_0004713, GO_0097366
Disease	cholesterol in medium LDL measurement	NECTIN2 APOB DOCK7	3.73e-03	49	187	3	EFO_0022224
Disease	Familial Alzheimer Disease (FAD)	RELN NECTIN2 CASS4 IDE	3.82e-03	100	187	4	C0276496
Disease	Alzheimer's Disease	RELN NECTIN2 CASS4 IDE	3.95e-03	101	187	4	C0002395
Disease	myelodysplastic syndrome (implicated_via_orthology)	SF3B1 EGR1	3.97e-03	15	187	2	DOID:0050908 (implicated_via_orthology)
Disease	brain edema (biomarker_via_orthology)	C5 ICAM1	3.97e-03	15	187	2	DOID:4724 (biomarker_via_orthology)
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	KIR2DL1 KIR2DL3	3.97e-03	15	187	2	EFO_0801746
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A MYO15A ATP2B2	4.17e-03	51	187	3	cv:CN043650
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	NECTIN2 APOB DOCK7	4.17e-03	51	187	3	EFO_0022302
Disease	cholesterol to total lipids in small HDL percentage	NECTIN2 APOB DOCK7	4.17e-03	51	187	3	EFO_0022240
Disease	phospholipids in IDL measurement	NECTIN2 APOB DOCK7	4.41e-03	52	187	3	EFO_0022164
Disease	total lipids in medium LDL	NECTIN2 APOB DOCK7	4.41e-03	52	187	3	EFO_0022180
Disease	type 2 diabetes mellitus (implicated_via_orthology)	INSRR ALMS1 FOXM1 IDE	4.54e-03	105	187	4	DOID:9352 (implicated_via_orthology)
Disease	cholesterol in small VLDL measurement	NECTIN2 APOB DOCK7	4.65e-03	53	187	3	EFO_0022228
Disease	free cholesterol to total lipids in small LDL percentage	NECTIN2 APOB DOCK7	4.65e-03	53	187	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	NECTIN2 APOB DOCK7	4.65e-03	53	187	3	EFO_0022258
Disease	age at menarche	KCNK9 SEMA6D ALMS1 PTPRN2 SCN2A DLG2 COL1A2 DPYD RBM6 SLC14A2	4.80e-03	594	187	10	EFO_0004703
Disease	cholesterol to total lipids in very large VLDL percentage	NECTIN2 APOB DOCK7	4.90e-03	54	187	3	EFO_0022244
Disease	gestational diabetes (is_marker_for)	AHSG ICAM1	5.10e-03	17	187	2	DOID:11714 (is_marker_for)
Disease	Alzheimer disease, brain volume measurement	PAK2 PKN2	5.10e-03	17	187	2	EFO_0006930, MONDO_0004975
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 ZNF292	5.10e-03	17	187	2	DOID:0060307 (is_implicated_in)
Disease	waist-hip ratio	CYTL1 BCL6 PTGR3 SCN2A DLAT DLG2 CNTN2 SHISA6 NDST1 DPYD FN1 RFX7 RBM6 KCNK5 SLC14A2 CUX1	5.14e-03	1226	187	16	EFO_0004343
Disease	complement factor H-related protein 1 measurement	FRMPD4 ZBTB41 CPN2	5.43e-03	56	187	3	EFO_0600054
Disease	triglycerides to total lipids in medium HDL percentage	NECTIN2 APOB DOCK7	5.43e-03	56	187	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	NECTIN2 APOB DOCK7	5.43e-03	56	187	3	EFO_0022316
Disease	cholesteryl esters to total lipids in medium HDL percentage	NECTIN2 APOB DOCK7	5.43e-03	56	187	3	EFO_0022251
Disease	interleukin-6 measurement	CASS4 AK8 ATP2B2 DCAF4	5.70e-03	112	187	4	EFO_0004810
Disease	neurofilament light chain measurement	VWA8 PTPRN2 MYO15A	5.70e-03	57	187	3	EFO_0009178
Disease	serum gamma-glutamyl transferase measurement	SEMA6D EIF2B4 NECTIN2 KMT2A TAF4 DNMBP CNOT4 ARAP2 ICAM1 OASL PKN2 DCAF4 ZNF292	5.71e-03	914	187	13	EFO_0004532
Disease	Dystonia, Paroxysmal	DLAT COL6A3	5.72e-03	18	187	2	C0393588
Disease	alcohol consumption measurement	RELN RPS6KA5 XKR4 SEMA6D ALMS1 SERGEF DNAH5 CNOT4 ARAP2 USP28 AK8 GRIP1 SPHKAP MYO15A SLC14A2 CUX1	5.81e-03	1242	187	16	EFO_0007878
Disease	Prostatic Neoplasms	NECTIN2 KMT2A KDM6A USP28 ARHGEF5 ICAM1 SF3B1 EGR1 SPEN ZNF292	6.15e-03	616	187	10	C0033578
Disease	Malignant neoplasm of prostate	NECTIN2 KMT2A KDM6A USP28 ARHGEF5 ICAM1 SF3B1 EGR1 SPEN ZNF292	6.15e-03	616	187	10	C0376358
Disease	Atherosclerosis	NECTIN2 ICAM1 TRIM28	6.28e-03	59	187	3	C0004153
Disease	triglycerides to total lipids in small LDL percentage	NECTIN2 APOB DOCK7	6.28e-03	59	187	3	EFO_0022337

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSKPDYRNSSPQVVP	ZNF280B	121	Q86YH2
TDVPVTVYATTRKPP	FAM229B	56	Q4G0N7
TTPNRLIYLLKQDPP	DDX52	291	Q9Y2R4
ARLLRTIPSPYPASK	DCAF4	446	Q8WV16
KPILVYPPLSTITAR	CFAP54	1006	Q96N23
ATVPLDIPPYTKNII	CPN2	41	P22792
NISRYLTDIKPLPPN	AMN1	21	Q8IY45
PVRASLPTLPSQVYD	CASS4	161	Q9NQ75
PLQKYTRLQTPSSFP	CTC1	536	Q2NKJ3
VDPTLRTKQPIPAAY	CDC73	276	Q6P1J9
SSSSVVPYLPRLPIL	ABL2	561	P42684
SGLKTVQPVPPFYRS	BNC2	561	Q6ZN30
KPYPSPKTIEDLATQ	CUX1	1266	P39880
LPQRPPKPAIYSSVT	ARHGEF5	631	Q12774
PVLPYVKESARRNPA	FAM220BP	76	B1ANY3
FLSPKLTYIPENTPI	FAT4	2051	Q6V0I7
PTSRSTPYKPIDDRI	SPATA5	246	Q8NB90
NLKTVQPVLPFYRSP	BNC1	481	Q01954
PQREKPSVLYPQVLS	ALMS1	1051	Q8TCU4
RRSPSKPTLAYPESN	CEP57	51	Q86XR8
RPFITSKPPVQYRNE	ABHD3	96	Q8WU67
SRTTPYEPKRGVPLS	DPYD	1006	Q12882
LQKPVLPLYRGSSVS	DNMBP	471	Q6XZF7
TVDYKLPRTVPDPLA	ADAM32	581	Q8TC27
DLYVPSSPILAPVRS	ARAP2	256	Q8WZ64
YVPDSPALSPIELKQ	CDK11B	406	P21127
NKVTYPPPLTLTEQT	CELSR1	2931	Q9NYQ6
QSPDLSPRYLKAVPD	FAM187A	196	A6NFU0
LNVTPKSPYTFKIPE	DENND3	506	A2RUS2
LTTTRKTPQGPPEIY	CDV3	176	Q9UKY7
LSRATPIPEYLKQIP	DCAF16	156	Q9NXF7
PPFRKPQTVAASSIY	TP53BP2	596	Q13625
ATEPPTETLLLRKPY	ATP2B2	926	Q01814
VKPLPPVYLTFTRES	IL13RA2	236	Q14627
PEYTEVELKQPLSLP	RBM20	1121	Q5T481
PRLDPPEDKTITTLY	RBM22	221	Q9NW64
LRTTVPRPAPYSKAL	RAB3GAP1	941	Q15042
TPAITLESPDIKYPL	CYB5R3	31	P00387
KPQSIIPPVQTLSYS	QSER1	296	Q2KHR3
PVSSPPEQKVGLYRR	OFD1	786	O75665
SYRPSQKDVEPPKIS	INTS12	46	Q96CB8
DLPKTYLRRPEASSP	PTPRN2	111	Q92932
VIASPFLPKYLSSPR	KLHL30	451	Q0D2K2
PSRPRYKADVPDLQS	KCNK9	281	Q9NPC2
LPPVYSQRGQPLTKI	MSGN1	151	A6NI15
SENPYATIKDPPVLI	MEGF10	1026	Q96KG7
ANIPDLPKSYIPSRL	PALMD	141	Q9NP74
TVSVLEYALPQRPPQ	PATL1	146	Q86TB9
RVLPSKQIASPIYLP	C22orf23	71	Q9BZE7
RPKTPPTDIIVYAEL	KIR2DL2	321	P43627
SRKSEYLLPVAPSKP	MYLK	606	Q15746
PLNPSYKSSPTRNIE	MAP7D2	211	Q96T17
PLLSDIRIDYPPSSV	ITIH5	481	Q86UX2
YIPPIITNRPTSKPT	NPNT	301	Q6UXI9
ELPVSPEIPPRKSQY	IL31RA	656	Q8NI17
QRPKTPPTDIIVYTE	KIR2DL3	321	P43628
FRSYLLPPPQTDDKI	MTMR10	11	Q9NXD2
LPEQKTLRPSLSYPL	MYO15A	1051	Q9UKN7
YRFLQKSPEQSPPAI	GPR155	831	Q7Z3F1
TLSYVLINPPPDTRL	KCNT1	1171	Q5JUK3
LNPPTPSIYLENKRD	KDM6A	936	O15550
LNPPTPSIYLESKRD	KDM6B	1181	O15054
YKEPAAPVSIQRSAP	LASP1	186	Q14847
LVETSYPSQTTRLPP	EGR1	116	P18146
QRPKTPPTDTILYTE	KIR3DL1	416	P43629
PPTDTILYTELPNAK	KIR3DL1	421	P43629
PSYPKILKVISADQP	AK8	231	Q96MA6
QNDLKPLFSPPSYRV	FAT2	141	Q9NYQ8
ALPPSLVPLVVYSKN	KCNK5	336	O95279
VTPTLNPLIYSLRNP	OR2Z1	281	Q8NG97
YRPTEVTDLKPQVPP	DLAT	306	P10515
TVTLPKNISYTLLPP	PCDH7	741	O60245
KLYITTKLPNPAFTP	DNAH8	3556	Q96JB1
FTYLPANVPIIKTEP	NFATC1	691	O95644
IPPSLNPTVYALQTK	OR56B1	291	Q8NGI3
PVTVAYSPKRSPKEN	MPHOSPH9	826	Q99550
NPKSPLLYVTRPSEV	NDST1	201	P52848
QAPPRETYLSEKIPI	SLC11A1	31	P49279
VKPSSLPPLIVYDRN	GGA2	481	Q9UJY4
EISRRILKSEPPYPQ	RPS6KA5	266	O75582
LTVRSNLIPSPPTYN	PTGS1	116	P23219
LEYPIPVTTVLPDRQ	CYTL1	121	Q9NRR1
ETPSGVKRLPEYPQV	EIF2B4	136	Q9UI10
APVLPELTAIPLTAY	MSI1	256	O43347
YKPSSLRTLPETLDP	NDUFB4	6	O95168
PIKPPVYNSRLVSPS	POU2F3	346	Q9UKI9
SKPPVIEGLSPTVYR	HIGD2A	16	Q9BW72
SAEPTTRTYDLNKPP	PRKG2	126	Q13237
ITLPLPPYTRSQATR	RELN	2441	P78509
NSQPPPEVYVSLIKA	OASL	166	Q15646
RVIKLSTNPFPAPYL	FANCB	526	Q8NB91
KSIYTRSVIDPVPAP	PAK2	191	Q13177
EPLAYIAQPPLNRKT	CCDC181	286	Q5TID7
PSREFQVPTFTIPKL	APOB	1331	P04114
RLPYTIITTPPLKDF	APOB	3136	P04114
QPRSAPSLRPKDYEV	COL1A2	1121	P08123
RYLTSIPDSIPPNVE	IGSF10	46	Q6WRI0
KATDLRPIYISVQPP	GUK1	111	Q16774
PAPPSQQSLYKRVAE	CARD14	476	Q9BXL6
LEKPPQAYSVLSPEV	DOCK7	691	Q96N67
SRAQLVPLPPSTYVE	AHSG	186	P02765
PSVSKYPLRNLQPAS	FN1	1046	P02751
RNIPLSYFLISPPKS	CDHR3	166	Q6ZTQ4
SILLTVIQPYPSPKS	FRMPD4	146	Q14CM0
TLLPVSKPEIRSYFP	C5	756	P01031
IQKLLASTRYPPPAV	COL6A3	1416	P12111
SPIAKYTLQARTPPA	CNTN2	636	Q02246
YRVSATDLPPELPKA	BCL6	691	P41182
SDLKEPPQPPRYISI	ENKUR	16	Q8TC29
KSREQPSVLSRYPPA	LUZP1	466	Q86V48
IKPNETVLTAFPYRP	MS4A14	16	Q96JA4
PPAVSYTKRPQANSV	MARK1	431	Q9P0L2
PQSRPGVSTLQVPKY	ITIH6	806	Q6UXX5
VYLRTLPAAPTVPQD	INSRR	596	P14616
LPRVSSYLVPIQFPV	FOXM1	371	Q08050
KVPRIRTPSYSPTQR	KMT2A	2141	Q03164
VISVEPLLPRYSPQS	KIAA1210	1011	Q9ULL0
SPLPPQYATQFLKRS	KIAA1210	1151	Q9ULL0
NAIYSLAARPLPVPK	CBL	671	P22681
TRPPEPVYSTVNKLC	DLG2	341	Q15700
PIKDIRNLYVTFPIP	IDE	306	P14735
TIYSFPAPNVILTKP	ICAM1	306	P05362
NRPVLVPYKLIRDSP	GTF2IRD1	821	Q9UHL9
LSPVTKPRSQTYPDV	GRIP1	846	Q9Y3R0
QVPRSPVIKISYSTP	PWWP2B	246	Q6NUJ5
PPLSAQYPREELTRV	SLFN13	716	Q68D06
RPKTPPTDIIVYTEL	KIR2DL1	321	P43626
PDLSARVTIYQVPLP	ECSIT	236	Q9BQ95
ATPVFIPLRSKPVYG	KYAT3	171	Q6YP21
LYSFQTSLPKLPVPR	CPT1B	166	Q92523
TKLPNPAYTPEISAR	DNAH5	3696	Q8TE73
KTSSIPLNELYPPLI	LRRN1	671	Q6UXK5
VYLKPPSNSPSVIDR	OR14A2	256	Q96R54
KDYLRELPTPLITQP	SYDE1	476	Q6ZW31
QVTSLAPTTRYPALP	SYT3	216	Q9BQG1
YPALPRPLTQQTLTS	SYT3	226	Q9BQG1
NSSPQPYLVPFLKRS	TAF4	646	O00268
PSPIYQLERRESSLP	USH2A	1496	O75445
ELITYPQPQKTSIPA	RBM6	571	P78332
YPTPLIKTERSPENL	SPHKAP	276	Q2M3C7
PALVQDPKVTYLSPD	SERGEF	406	Q9UGK8
PLENLKVYISSRPPL	TMEM248	6	Q9NWD8
KPPERTPEDLNTIYS	RAPGEF6	16	Q8TEU7
TDAPYFLPRQVPKSL	TATDN2	706	Q93075
KEPIQPSVLRRTYNP	SYT17	136	Q9BSW7
PEKQTVPTPVRKYNS	FILIP1	1041	Q7Z7B0
LPQDSYTVVRKPKPS	NHSL2	916	Q5HYW2
QRNPRYEKLTPVPDS	PRPF6	171	O94906
PPYPTSRRQTFITLE	RIF1	1211	Q5UIP0
TPKPYISSSNLNPRE	PSG9	146	Q00887
SSNELALPSYPKPVR	RUFY1	676	Q96T51
VPDPDVSIYLPVLKT	HUS1	151	O60921
RPAVKKESTLPPRTY	PRRC2C	1156	Q9Y520
YTPVRTAKQTPEKPR	SHISA6	256	Q6ZSJ9
LNPRTPRKLTPYTVV	NLRP7	161	Q8WX94
SRSIYVKFPLLKPSP	IARS2	266	Q9NSE4
KEPRPPSYTISIVGL	ARHGAP5	6	Q13017
ILPKSQSEYKPDTPQ	PKN2	616	Q16513
PSLRPSPKAVLELYS	RIPOR2	396	Q9Y4F9
FPPLTQIKLQRYPES	TET1	1236	Q8NFU7
PRYPKLAALNPESNT	CLIC1	91	O00299
YVDKSLSVPIEPPQI	C10orf90	266	Q96M02
VTPLQRYDTPIDKPS	CNOT4	266	O95628
VPAVSLYPSRKKVPV	RAPGEF2	1056	Q9Y4G8
SYENLLRTPTPPEVT	SKA3	351	Q8IX90
VSSKRIPYAPSGEIP	UGDH	466	O60701
NRQISTYITVPPSPL	ZNF341	111	Q9BYN7
YTKASVVLFLPNPRP	nan	71	Q6ZUT4
NTPTLPSITYSIRPE	SPEN	3101	Q96T58
PRLVSRTPGTAPKYD	ILDR2	511	Q71H61
YVPIRTPARKLTATP	SF3B1	421	O75533
ADKPISYRTKPPASI	RASGEF1C	176	Q8N431
PPRISVPQDPKSSYL	SPATA31D1	1186	Q6ZQQ2
RSQSSKAAIPPPVYE	RBM17	201	Q96I25
YQELPPSPDQRKLLS	ZBTB41	51	Q5SVQ8
ELPYTPPLESKQRRN	TMEM131	1486	Q92545
QVYNVRTVSLPPPDL	TRMT61A	236	Q96FX7
TPALYILTPFNPIRK	SCN2A	106	Q99250
KPVSQSLEFPTRYSP	ZNF292	2096	O60281
SPSPPRLQYKDDALI	XKR4	626	Q5GH76
YTVLLRIAPAPTPTD	PPP1R3F	281	Q6ZSY5
RYPQILPKPANTSAL	RFX7	331	Q2KHR2
IVLKEPPTIRPNSPY	USP28	1041	Q96RU2
TSDPRLPYKVLSVPE	UFM1	11	P61960
TPVPSVKPEYLTLLV	PTGR3	141	Q8N4Q0
SVKYPEDVPITLPNL	TXNDC11	776	Q6PKC3
LFTTSPLTLQYVPRP	TRIM49D1	391	C9J1S8
IPLYSKVQRPCTSTP	USP10	446	Q14694
SVEEPLPRPLTSLYI	ZNF818P	11	Q6ZRF7
SLEPQTRPTDKYLPP	PLEKHG7	121	Q6ZR37
TRPTDKYLPPELQPV	PLEKHG7	126	Q6ZR37
TSVYPTLSQQLPREP	TRAPPC10	31	P48553
NPLRVVTKPPYEITE	YEATS4	76	O95619
LKDIYPKDVTPPQTS	VWA8	1436	A3KMH1
SEVPPKVPNREASLY	SEMA6D	916	Q8NFY4
KVPNREASLYSPPST	SEMA6D	921	Q8NFY4
NPAIFRLPLSKVTYP	SLC14A2	416	Q15849
NSSITLKDDIPPIYP	UHRF1BP1	1321	Q6BDS2
PRTTENPTLERKPYS	ZFYVE26	1276	Q68DK2
NPTLERKPYSSPRDS	ZFYVE26	1281	Q68DK2
KIIPKYISENESPRP	USP1	316	O94782
RLQEKLSPPYSSPQE	TRIM28	746	Q13263
NLVPTYIPDREITPL	MYO7A	1411	Q13402
EEPALIPVTLSVRYP	NECTIN2	246	Q92692